Age and Endothelial Progenitor Cell Mobilization

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

123 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-07-31

Study Completion Date

2008-10-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It is hypothesized that aging is associated with reduced vascular injury-induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased vascular disease. Patients with stable coronary artery disease will be enrolled in this observational study and will undergo either angiography alone or angiography and angioplasty. Participants will be followed for 5 years.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endovascular Treatment of Thoracic Aortic Disease

NCT00583817

Thoracic Aortic Aneurysms Dissecting, Aneurysm Ascending Aorta Aneurysm +6 more

ENROLLING_BY_INVITATION NA

The Biomechanical Study of Diseased Human Carotid, Femoral and Abdominal Aortic Tissue

NCT05802706

Vascular Diseases

RECRUITING

Circulating microRNAs and Degenerative Abdominal Aorta Aneurysm

NCT03974958

Abdominal Aorta Aneurysm

COMPLETED NA

Registry in Patients With Thoracoabdominal Aneurysms

NCT03295682

Thoracoabdominal Aneurysm

ACTIVE_NOT_RECRUITING

Trial on Endovascular Aneurysm Management

NCT00537134

Brain Aneurysm

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Coronary artery disease is a leading cause of morbidity and mortality in our society. It is initiated by the dysfunction of the lining of coronary arteries. Such endothelial dysfunction permits vascular wall inflammation, smooth muscle cell proliferation, and thrombosis, which progresses to coronary artery stenosis and occlusion, and manifests as myocardial ischemia and infarction. Endothelial injury can be due to the damaging effects of various cardiovascular risk factors and it can also be induced by balloon injury associated with coronary angioplasty. Damaged endothelium can be repaired via endogenous mechanisms, such as by the migration and proliferation of neighboring uninjured mature endothelial cells, or by the mobilization and homing of bone-marrow-derived circulating endothelial progenitor cells (EPCs).

There are several repair mechanisms that are now thought to involve circulating endothelial progenitor cells that are mobilized from the bone marrow and home to sites of endothelial injury. The researchers of this study hypothesize that aging is associated with reduced vascular injury induced endothelial progenitor cell activity, resulting in impaired vascular repair and increased coronary heart disease events. Patients with stable coronary artery disease will be enrolled in this study. They will undergo either angiography alone or angiography and angioplasty. Venous blood will be collected immediately prior to the procedure and 20-24 hours after the procedure. The number of endothelial progenitor cells will be assessed based on their ability to form colonies and also to migrate under the influence of certain growth factors. These values will be compared between both samples. Study participants will also be contacted at 6 months, and 2 and 5 years after their participation in the study. The clinical outcomes of the participant's coronary artery disease will be correlated with the number of endothelial progenitor cells.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Angiography

Patients undergoing coronary angiography without percutaneous coronary angioplasty

Angiography

Intervention Type PROCEDURE

Angiography is an imaging technique to see coronary blood vessels.

Percutaneous Coronary Angioplasty

Patients with stable coronary artery disease undergoing angioplasty

Percutaneous Coronary Angioplasty

Intervention Type PROCEDURE

This is a procedure by which the blood vessels of the heart are imaged with an insertion of a catheter in the groin and blocked arteries are opened.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Coronary Angioplasty

This is a procedure by which the blood vessels of the heart are imaged with an insertion of a catheter in the groin and blocked arteries are opened.

Intervention Type PROCEDURE

Angiography

Angiography is an imaging technique to see coronary blood vessels.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients having stable coronary artery disease and undergoing either angiography or angioplasty

Exclusion Criteria

* Unstable coronary artery disease associated with either EKG changes or elevation of cardiac enzymes
* Coronary intervention in the past 3 months
* Renal insufficiency
* Malignancy within the past 5 years except non-melanomatous skin cancers
* Recent infection within the past 3 months requiring antibiotic treatment
* Recent surgery requiring anesthesia within the past 3 months
* Having inflammatory disease
* Chemotherapy, radiation therapy or bone marrow stimulants at any time in the past
* Menstruating women
* Recent changes in statin, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blocker doses

Eligible Sex

ALL

Accepts Healthy Volunteers

No